http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103110950-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
| filingDate | 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103110950-B |
| titleOfInvention | A kind of application of pharmaceutical composition |
| abstract | The invention discloses pharmaceutical composition application in preparing anti-extrusion vulnerary thing, wherein, described pharmaceutical composition contains muscarinic acceptor blocker and cholinesterase inhibitor.The pharmaceutical composition of the present invention is used for treating crush injury, and it acts on enhancing, and effect is notable, and toxic and side effects is little, overcomes the side effect that existing medicine often results in. |
| priorityDate | 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.